Sökning: "pharmaceutical abuse"
Visar resultat 1 - 5 av 24 uppsatser innehållade orden pharmaceutical abuse.
1. Opioidbehandling vid narkotikamissbruk : En jämförelse mellan buprenorfin och metadonbehandling
Kandidat-uppsats, Linnéuniversitetet/Institutionen för kemi och biomedicin (KOB)Sammanfattning : Bakgrund: Missbruk av opioider är substanser med morfinliknande effekter har ökat i hela världen men framförallt i USA och senaste åren även i Europa. År 2016 var det 11,8 miljoner amerikanare som var 12 år eller äldre och som missbrukade farmaceutiska opioider (92%), kombination av opioider och heroin (5,4%) eller endast heroin (2,6%). LÄS MER
2. The Guide: A Journey Through Holistic Healing
Master-uppsats, Linnéuniversitetet/Institutionen för design (DE)Sammanfattning : The Graphic Journalism genre is emerging with influences from war reportage with authors like Joe Sacco. I would like to address and report the “War on Drugs” from small first hand experiences, personal connections, and a genuine deep desire to see the healthcare and justice system change. LÄS MER
3. EU Competition Law under Ordoliberalism - A case study of Excessive Pricing in Pharmaceutical Sector
Magister-uppsats, Malmö universitet/Fakulteten för kultur och samhälle (KS)Sammanfattning : The purpose of this study is to conceptualize the ideational influence of Ordoliberalism on EU Competition Law while addressing a problematic social issue that has been witnessing a surge in the number of cases, which is excessive price abuse under Article 102(a) of the Treaty on the Functioning of the European Union (TFEU) within the spectrum of pharmaceutical sector. By utilizing Nedergaard (2020)’s analytic framework for Ordoliberalism’s operationalization, the study successfully proves the impacts of five characteristics of Ordoliberalism, including Politics by rules, Economic Constitution, Market Construction, Role of Consumers and Role of the states towards consumers, on the practices of EU Competition Law, using the empirical data collected from two excessive pricing examples: Aspen in Italy and Pfizer/Flynn in the United Kingdom. LÄS MER
4. Pay-for-delay i läkemedelssektorn ur ett konkurrensrättsligt perspektiv
Kandidat-uppsats, Lunds universitet/Juridiska institutionen; Lunds universitet/Juridiska fakultetenSammanfattning : The pharmaceutical market in the EU is very complex because of its many actors with different economic and political interests as well as its legal framework. Because of these interests, the market structure as well as the structure of EU competition law and patent law, various situations arise where so-called pay-for-delay agreements are pushing the framework to its limits. LÄS MER
5. Reverse payment settlements in the context of Article 102 TFEU: Abusive or not? By object or not?
Magister-uppsats, Lunds universitet/Juridiska institutionenSammanfattning : Pharmaceutical reverse payment settlements lie at the intersection of competition law and intellectual property law. In the recent years, these settlement agreements have increasingly attracted the attention of competition law authorities in the European Union. LÄS MER